BOULDER, Colo. (AP) _ Brickell Biotech, Inc. (BBI) on Tuesday reported a loss of $13.3 million in its third quarter.

On a per-share basis, the Boulder, Colorado-based company said it had a loss of 16 cents.

The drug developer posted revenue of $132,000 in the period.

In the final minutes of trading on Tuesday, the company's shares hit 40 cents. A year ago, they were trading at 52 cents.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BBI at https://www.zacks.com/ap/BBI

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News